PACS Group CEO Hulse sells $5.6m in PACS stock

Jason Hulse, the Co-Founder, CEO, and Chairman of PACS Group Inc. (PACS), recently sold about $5.6 million worth of the company's common stock between October 14 and October 16, 2026. This sale consisted of 118,729 shares, each traded at prices between $45.00 and $48.1052. Hulse, who also holds a 10% stake in the company, saw his direct ownership of PACS stock decrease to 54,316,520 shares post-sale.

The insider transaction took place while PACS stock reached a 52-week high of $49.49, following a substantial 277% return over the past year. Analysts at InvestingPro suggest the stock is currently overvalued compared to its Fair Value, though it has shown strong momentum recently. The sales were made under a Rule 10b5-1 trading plan that Hulse established on May 18, 2026.

For those interested in a more detailed analysis of PACS Group’s valuation and performance, InvestingPro offers a Pro Research Report with expert insights and tips. Additionally, PACS Group recently announced the acquisition of 32 skilled nursing facilities in Florida, expanding its reach with 4,049 new beds, expected to be finalized by the end of the fourth quarter.

The company has also completed further closings on its Eduro Healthcare transaction, reinforcing its market presence. Leadership changes at PACS Group include the appointment of Patrick J. Murphy as Chief Legal Officer and Corporate Secretary, replacing John Mitchell. This restructuring reflects the company’s ongoing strategic growth.

This report, produced with AI assistance and reviewed by an editor, provides a comprehensive overview of PACS Group's recent developments.